Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbiota Transplant Therapy to Prevent HE Recurrence in a Phase 2B Multi-Center Trial of Veterans With Cirrhosis

NCT07528690 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT07528690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07528690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbiota Transplant Therapy to Prevent HE Recurrence in a Phase 2B Multi-Center Trial of Veterans With Cirrhosis
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 30, 2026
Completion date
March 3, 2031
Enrollment
162 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatic encephalopathy